Elevance Health Inc. (ELV)
NYSE: ELV · IEX Real-Time Price · USD
519.96
+2.72 (0.53%)
Mar 27, 2024, 4:00 PM EDT - Market closed
Elevance Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1998 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 171,340 | 156,595 | 138,639 | 121,867 | 104,213 | 92,105 | 90,040 | 84,863 | 79,157 | 73,874 | Upgrade
|
Revenue Growth (YoY) | 9.42% | 12.95% | 13.76% | 16.94% | 13.15% | 2.29% | 6.10% | 7.21% | 7.15% | 4.01% | Upgrade
|
Cost of Revenue | 141,623 | 129,677 | 113,466 | 96,998 | 83,778 | 71,895 | 72,236 | 66,834 | 61,117 | 56,855 | Upgrade
|
Gross Profit | 29,717 | 26,918 | 25,173 | 24,869 | 20,435 | 20,210 | 17,804 | 18,029 | 18,040 | 17,019 | Upgrade
|
Selling, General & Admin | 20,087 | 17,700 | 15,918 | 17,450 | 13,364 | 14,020 | 12,650 | 12,559 | 12,535 | 11,748 | Upgrade
|
Other Operating Expenses | 885 | 767 | 441 | 361 | 338 | 358 | 169 | 192 | 230.1 | 220.9 | Upgrade
|
Operating Expenses | 20,972 | 18,467 | 16,359 | 17,811 | 13,702 | 14,378 | 12,819 | 12,751 | 12,765 | 11,969 | Upgrade
|
Operating Income | 8,745 | 8,451 | 8,814 | 7,058 | 6,733 | 5,832 | 4,985 | 5,278 | 5,275 | 5,050 | Upgrade
|
Interest Expense / Income | 1,030 | 851 | 798 | 784 | 746 | 753 | 739 | 723 | 653 | 600.7 | Upgrade
|
Other Expense / Income | 4 | -6 | 12 | 36 | 2 | 11 | 282 | - | -9.3 | 71.5 | Upgrade
|
Pretax Income | 7,711 | 7,606 | 8,004 | 6,238 | 5,985 | 5,068 | 3,964 | 4,555 | 4,631 | 4,378 | Upgrade
|
Income Tax | 1,724 | 1,712 | 1,846 | 1,666 | 1,178 | 1,318 | 121 | 2,085 | 2,071 | 1,808 | Upgrade
|
Net Income | 5,987 | 5,894 | 6,158 | 4,572 | 4,807 | 3,750 | 3,843 | 2,470 | 2,560 | 2,570 | Upgrade
|
Net Income Growth | 1.58% | -4.29% | 34.69% | -4.89% | 28.19% | -2.42% | 55.59% | -3.52% | -0.38% | 3.21% | Upgrade
|
Shares Outstanding (Basic) | 235 | 239 | 243 | 249 | 254 | 259 | 257 | 263 | 261 | 270 | Upgrade
|
Shares Change | -1.62% | -1.60% | -2.41% | -1.92% | -1.96% | 0.73% | -2.53% | 0.91% | -3.29% | -8.62% | Upgrade
|
EPS (Basic) | 25.38 | 24.56 | 25.26 | 18.23 | 18.81 | 14.53 | 14.70 | 9.39 | 9.73 | 9.31 | Upgrade
|
EPS (Diluted) | 25.22 | 24.28 | 24.95 | 17.98 | 18.47 | 14.19 | 14.35 | 9.21 | 9.38 | 8.99 | Upgrade
|
EPS Growth | 3.87% | -2.69% | 38.77% | -2.65% | 30.16% | -1.11% | 55.81% | -1.81% | 4.34% | 9.63% | Upgrade
|
Free Cash Flow | 6,765 | 7,247 | 7,277 | 9,667 | 4,984 | 2,619 | 3,394 | 2,686 | 3,609 | 2,743 | Upgrade
|
Free Cash Flow Per Share | 28.79 | 30.34 | 29.98 | 38.87 | 19.66 | 10.13 | 13.22 | 10.20 | 13.82 | 10.16 | Upgrade
|
Dividend Per Share | 5.920 | 5.120 | 4.520 | 3.800 | 3.200 | 3.000 | 2.700 | 2.600 | 2.500 | 1.752 | Upgrade
|
Dividend Growth | 15.63% | 13.27% | 18.95% | 18.75% | 6.67% | 11.11% | 3.85% | 4.00% | 42.69% | 16.80% | Upgrade
|
Gross Margin | 17.34% | 17.19% | 18.16% | 20.41% | 19.61% | 21.94% | 19.77% | 21.24% | 22.79% | 23.04% | Upgrade
|
Operating Margin | 5.10% | 5.40% | 6.36% | 5.79% | 6.46% | 6.33% | 5.54% | 6.22% | 6.66% | 6.84% | Upgrade
|
Profit Margin | 3.49% | 3.76% | 4.44% | 3.75% | 4.61% | 4.07% | 4.27% | 2.91% | 3.23% | 3.48% | Upgrade
|
Free Cash Flow Margin | 3.95% | 4.63% | 5.25% | 7.93% | 4.78% | 2.84% | 3.77% | 3.17% | 4.56% | 3.71% | Upgrade
|
Effective Tax Rate | 22.36% | 22.51% | 23.06% | 26.71% | 19.68% | 26.01% | 3.05% | 45.77% | 44.72% | 41.30% | Upgrade
|
EBITDA | 10,486 | 10,132 | 10,104 | 8,176 | 7,864 | 6,953 | 5,594 | 6,190 | 6,192 | 5,829 | Upgrade
|
EBITDA Margin | 6.12% | 6.47% | 7.29% | 6.71% | 7.55% | 7.55% | 6.21% | 7.29% | 7.82% | 7.89% | Upgrade
|
Depreciation & Amortization | 1,745 | 1,675 | 1,302 | 1,154 | 1,133 | 1,132 | 891 | 912 | 907.9 | 851 | Upgrade
|
EBIT | 8,741 | 8,457 | 8,802 | 7,022 | 6,731 | 5,821 | 4,703 | 5,278 | 5,284 | 4,978 | Upgrade
|
EBIT Margin | 5.10% | 5.40% | 6.35% | 5.76% | 6.46% | 6.32% | 5.22% | 6.22% | 6.68% | 6.74% | Upgrade
|